Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Imunon, Inc.

Equities

IMNN

US15117N6022

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-08 pm EDT 		5-day change 1st Jan Change
1.35 USD -0.74% Intraday chart for Imunon, Inc. +7.14% +98.53%
Jun. 24 Imunon, Inc. Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer CI
Jun. 05 IMUNON, Inc. Announces First Participants Vaccinated in IMNN-101 Phase 1 Clinical Trial CI

Evolution of the average Target Price on Imunon, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4ddaf1b55babea8ad5.8WdtI3vB83fAN3KfApkw14Ih6Nj-DMWadpmjKj6r5Ys.shQPfDT1gBqpVhXwd_MC5td3m5SKfbHiGfbseg_xtsGcBTUSFPiKObVDJw~e5097ae04bf086c78e492e63d7274001

Analyst Recommendations on Imunon, Inc.

HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating MT
Alliance Global Starts Imunon at Buy with $15 Price Target MT
HC Wainwright Starts Celsion at Buy With $16 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.35 USD
Average target price
10 USD
Spread / Average Target
+640.74%
High Price Target
12 USD
Spread / Highest target
+788.89%
Low Price Target
8 USD
Spread / Lowest Target
+492.59%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Imunon, Inc.

HC Wainwright
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Consensus Imunon, Inc.